MedPath

A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) Patients

Conditions
Parkinson's Disease
Registration Number
NCT01502384
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

This is a longitudinal study in healthy 1st degree relatives of patients with Parkinson's Disease (PD) carriers of a genetic mutation in genes that are known to increase the risk for PD. The purpose of this study is to explore the association between genetic mutations in the known genes and early preclinical symptoms such as motor, sensory, autonomic, behavioral and cognitive functions.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • healthy 1ST degree relatives of PD patients with known genotype that participated in an earlier genetic study at the sourasky medical center.
Exclusion Criteria
  • subjects with cognitive decline by the parameters defined in DSM- IV
  • subjects with psychiatric disorder
  • subjects unable to sign a consent form

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Tel Aviv Sourasky Medical Center
🇮🇱Tel Aviv, Israel
Anat Mirelman, PhD
Contact
972-3-6974958
anatmi@tasmc.health.gov.il
Nir Giladi, MD, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.